Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers

Author(s):  Gorman Shellie

Issue:  Mar/Apr 2000 - Compounding for Diabetes Patients
View All Articles in Issue

Page(s):  94-96

L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers Page 1
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers Page 2
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers Page 3

Download in electronic PDF format for $75

Abstract:  Diabetic foot ulcers are the most common cause of nontraumatic amputations and are responsible for 25% of all hospitalizations of patients with diabetes. Poor blood flow due to vascular endothelial dysfunction is considered the underlying cause of this condition. L-arginine is converted in the body to nitric oxide, a potent vasodilator, so supplementation with it may help increase vascular blood flow to ulcerated areas. Ascorbic acid has also been shown to improve endothelial-dependent vasodilation in diabetic patients. Together these nutrients may aid healing of diabetic foot ulcers. The author discusses physiology and topical treatment of diabetic foot ulcers. She then briefly describes ingredients in two sample formulations included with the article that may be of assistance, L-Arginine and Ascorbic Acid Hydrating Ulcer Gel, and L-Arginine and Ascorbic Acid in PLO (L-arginine, ascorbic acid, zinc sulfate, methylcellulose, propylene glycol, methylparaben, purified water, poloxamers, lecithin and isopropyl palmitate). She concludes that use of an appropriate topical dressing to treat diabetic foot ulcers can accelerate healing. While further studies are needed to determine the benefit from L-arginine and ascorbic acid, sufficient data exist to imply benefits for the diabetic patient.

Related Keywords: diabetic foot ulcers, amputations, L-arginine, dry wound, wet wound, PLO gel, ascorbic acid, zinc sulfate, astringent antiseptic, antioxidant, vasodilator, methylcellulose, propylene glycol, methylparaben, purified water, poloxamers, lecithin, isopropyl palmitate

Related Categories: DIABETES, WOUND CARE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Gorman Shellie
Mar/Apr 2000
Pg. 94-96

Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
Jul/Aug 2004
Pg. 265-267

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
May/Jun 2020
Pg. 182-186

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 278-281

Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E
, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017
Pg. 22-27

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Options in Wound Care
Kincaid Michele R
Mar/Apr 2002
Pg. 92-95

A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
Nov/Dec 2004
Pg. 458-460

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Vail Jane
Jan/Feb 2003
Pg. 21-23

Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
, Thompson Chad
Nov/Dec 2024
Pg. 455-458

Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 1999
Pg. 309-310

The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Harshbarger Robert
, Harshbarger Diana
Mar/Apr 2000
Pg. 84-87

Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
Jan/Feb 2022
Pg. 53

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488

Ascorbic acid 5% Topical Microemulsion
Allen Loyd V Jr
Sep/Oct 2022
Pg. 423

Ascorbic Acid 250-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 240

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
Sep/Oct 2015
Pg. 410

Return to Top